Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection.

Ying L, Ferrero RL.

Curr Top Microbiol Immunol. 2019;421:159-177. doi: 10.1007/978-3-030-15138-6_7. Review.

PMID:
31123889
2.

Complete genome sequence of Helicobacter pylori B128 7.13 and a single-step method for the generation of unmarked mutations.

Dawson EM, Dunne KA, Richardson EJ, Praszkier J, Alfawaz D, Woelfel S, De Paoli A, Chaudhry H, Henderson IR, Ferrero RL, Rossiter AE.

Helicobacter. 2019 Aug;24(4):e12587. doi: 10.1111/hel.12587. Epub 2019 May 7.

PMID:
31062466
3.

NLRC5 deficiency has a moderate impact on immunodominant CD8+ T-cell responses during rotavirus infection of adult mice.

Sun T, Ferrero RL, Girardin SE, Gommerman JL, Philpott DJ.

Immunol Cell Biol. 2019 Feb 15. doi: 10.1111/imcb.12244. [Epub ahead of print]

PMID:
30768806
4.

Mouse Models Of Helicobacter Infection And Gastric Pathologies.

D'Costa K, Chonwerawong M, Tran LS, Ferrero RL.

J Vis Exp. 2018 Oct 18;(140). doi: 10.3791/56985.

PMID:
30394371
5.

Helicobacter pylori Outer Membrane Vesicle Size Determines Their Mechanisms of Host Cell Entry and Protein Content.

Turner L, Bitto NJ, Steer DL, Lo C, D'Costa K, Ramm G, Shambrook M, Hill AF, Ferrero RL, Kaparakis-Liaskos M.

Front Immunol. 2018 Jul 2;9:1466. doi: 10.3389/fimmu.2018.01466. eCollection 2018.

6.

Membrane vesicles from Pseudomonas aeruginosa activate the noncanonical inflammasome through caspase-5 in human monocytes.

Bitto NJ, Baker PJ, Dowling JK, Wray-McCann G, De Paoli A, Tran LS, Leung PL, Stacey KJ, Mansell A, Masters SL, Ferrero RL.

Immunol Cell Biol. 2018 Nov;96(10):1120-1130. doi: 10.1111/imcb.12190. Epub 2018 Aug 14.

PMID:
30003588
7.

The Use of CRISPR/Cas9 Gene Editing to Confirm Congenic Contaminations in Host-Pathogen Interaction Studies.

Ferrand J, Croft NP, Pépin G, Diener KR, Wu D, Mangan NE, Pedersen J, Behlke MA, Hayball JD, Purcell AW, Ferrero RL, Gantier MP.

Front Cell Infect Microbiol. 2018 Mar 19;8:87. doi: 10.3389/fcimb.2018.00087. eCollection 2018.

8.

Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.

O'Reilly LA, Putoczki TL, Mielke LA, Low JT, Lin A, Preaudet A, Herold MJ, Yaprianto K, Tai L, Kueh A, Pacini G, Ferrero RL, Gugasyan R, Hu Y, Christie M, Wilcox S, Grumont R, Griffin MDW, O'Connor L, Smyth GK, Ernst M, Waring P, Gerondakis S, Strasser A.

Immunity. 2018 Mar 20;48(3):570-583.e8. doi: 10.1016/j.immuni.2018.03.003.

9.

Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.

Hill DG, Yu L, Gao H, Balic JJ, West A, Oshima H, McLeod L, Oshima M, Gallimore A, D'Costa K, Bhathal PS, Sievert W, Ferrero RL, Jenkins BJ, Jones GW.

Int J Cancer. 2018 Jul 1;143(1):167-178. doi: 10.1002/ijc.31298. Epub 2018 Feb 19.

10.

NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells.

Tran LS, Tran D, De Paoli A, D'Costa K, Creed SJ, Ng GZ, Le L, Sutton P, Silke J, Nachbur U, Ferrero RL.

Cell Microbiol. 2018 May;20(5):e12826. doi: 10.1111/cmi.12826. Epub 2018 Feb 15.

PMID:
29392836
11.

Isolation of Mouse Primary Gastric Epithelial Cells to Investigate the Mechanisms of Helicobacter pylori Associated Disease.

Tran LS, Ferrero RL.

Methods Mol Biol. 2018;1725:119-126. doi: 10.1007/978-1-4939-7568-6_10.

PMID:
29322413
12.

Bacterial membrane vesicles transport their DNA cargo into host cells.

Bitto NJ, Chapman R, Pidot S, Costin A, Lo C, Choi J, D'Cruze T, Reynolds EC, Dashper SG, Turnbull L, Whitchurch CB, Stinear TP, Stacey KJ, Ferrero RL.

Sci Rep. 2017 Aug 1;7(1):7072. doi: 10.1038/s41598-017-07288-4.

13.

Regulation and functions of inflammasome-mediated cytokines in Helicobacter pylori infection.

Tran LS, Chonwerawong M, Ferrero RL.

Microbes Infect. 2017 Sep - Oct;19(9-10):449-458. doi: 10.1016/j.micinf.2017.06.005. Epub 2017 Jul 6. Review.

PMID:
28690082
14.

A Helicobacter pylori Homolog of Eukaryotic Flotillin Is Involved in Cholesterol Accumulation, Epithelial Cell Responses and Host Colonization.

Hutton ML, D'Costa K, Rossiter AE, Wang L, Turner L, Steer DL, Masters SL, Croker BA, Kaparakis-Liaskos M, Ferrero RL.

Front Cell Infect Microbiol. 2017 Jun 6;7:219. doi: 10.3389/fcimb.2017.00219. eCollection 2017.

15.

Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition.

Baker PJ, De Nardo D, Moghaddas F, Tran LS, Bachem A, Nguyen T, Hayman T, Tye H, Vince JE, Bedoui S, Ferrero RL, Masters SL.

Physiol Rev. 2017 Jul 1;97(3):1165-1209. doi: 10.1152/physrev.00026.2016. Review.

16.

Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.

Pathak A, Blair VL, Ferrero RL, Kedzierski L, Andrews PC.

J Inorg Biochem. 2017 Dec;177:266-275. doi: 10.1016/j.jinorgbio.2017.05.014. Epub 2017 May 31.

PMID:
28583712
17.

Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.

Chonwerawong M, Avé P, Huerre M, Ferrero RL.

Gut Pathog. 2016 Nov 21;8:61. eCollection 2016.

18.

Des-acyl ghrelin inhibits the capacity of macrophages to stimulate the expression of aromatase in breast adipose stromal cells.

Au CC, Docanto MM, Zahid H, Raffaelli FM, Ferrero RL, Furness JB, Brown KA.

J Steroid Biochem Mol Biol. 2017 Jun;170:49-53. doi: 10.1016/j.jsbmb.2016.07.005. Epub 2016 Jul 14.

PMID:
27423512
19.

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Menheniott TR, O'Connor L, Chionh YT, Däbritz J, Scurr M, Rollo BN, Ng GZ, Jacobs S, Catubig A, Kurklu B, Mercer S, Minamoto T, Ong DE, Ferrero RL, Fox JG, Wang TC, Sutton P, Judd LM, Giraud AS.

J Clin Invest. 2016 Apr 1;126(4):1383-400. doi: 10.1172/JCI82655. Epub 2016 Mar 14.

20.

Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.

Pathak A, Blair VL, Ferrero RL, Junk PC, Tabor RF, Andrews PC.

Dalton Trans. 2015 Oct 14;44(38):16903-13. doi: 10.1039/c5dt02259b. Epub 2015 Sep 9.

PMID:
26352159
21.

Immune modulation by bacterial outer membrane vesicles.

Kaparakis-Liaskos M, Ferrero RL.

Nat Rev Immunol. 2015 Jun;15(6):375-87. doi: 10.1038/nri3837. Epub 2015 May 15. Review.

PMID:
25976515
22.

Increased Outer Membrane Vesicle Formation in a Helicobacter pylori tolB Mutant.

Turner L, Praszkier J, Hutton ML, Steer D, Ramm G, Kaparakis-Liaskos M, Ferrero RL.

Helicobacter. 2015 Aug;20(4):269-83. doi: 10.1111/hel.12196. Epub 2015 Feb 9.

PMID:
25669590
23.

Bismuth(III) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6].

Pathak A, Blair VL, Ferrero RL, Mehring M, Andrews PC.

Chem Commun (Camb). 2014 Dec 14;50(96):15232-4. doi: 10.1039/c4cc07329k.

PMID:
25341969
24.

Bismuth(III) complexes derived from α-amino acids: the impact of hydrolysis and oxido-cluster formation on their activity against Helicobacter pylori.

Busse M, Border E, Junk PC, Ferrero RL, Andrews PC.

Dalton Trans. 2014 Dec 28;43(48):17980-90. doi: 10.1039/c4dt02505a. Epub 2014 Oct 14.

PMID:
25310996
25.

The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.

Irving AT, Mimuro H, Kufer TA, Lo C, Wheeler R, Turner LJ, Thomas BJ, Malosse C, Gantier MP, Casillas LN, Votta BJ, Bertin J, Boneca IG, Sasakawa C, Philpott DJ, Ferrero RL, Kaparakis-Liaskos M.

Cell Host Microbe. 2014 May 14;15(5):623-35. doi: 10.1016/j.chom.2014.04.001. Epub 2014 Apr 17.

26.

Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.

Andrews PC, Blair VL, Ferrero RL, Junk PC, Kedzierski L, Peiris RM.

Dalton Trans. 2014 Jan 21;43(3):1279-91. doi: 10.1039/c3dt52544a. Epub 2013 Nov 5.

PMID:
24190067
27.

Recognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive Immunity.

Ferrand J, Ferrero RL.

Front Immunol. 2013 Oct 21;4:344. doi: 10.3389/fimmu.2013.00344. Review.

28.

Helicobacter pylori cag pathogenicity island (cagPAI) involved in bacterial internalization and IL-8 induced responses via NOD1- and MyD88-dependent mechanisms in human biliary epithelial cells.

Boonyanugomol W, Chomvarin C, Hahnvajanawong C, Sripa B, Kaparakis-Liaskos M, Ferrero RL.

PLoS One. 2013 Oct 15;8(10):e77358. doi: 10.1371/journal.pone.0077358. eCollection 2013.

29.

Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tiger.

Tegtmeyer N, Rivas Traverso F, Rohde M, Oyarzabal OA, Lehn N, Schneider-Brachert W, Ferrero RL, Fox JG, Berg DE, Backert S.

PLoS One. 2013 Aug 5;8(8):e71220. doi: 10.1371/journal.pone.0071220. Print 2013.

30.

Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway.

Weiss G, Forster S, Irving A, Tate M, Ferrero RL, Hertzog P, Frøkiær H, Kaparakis-Liaskos M.

MBio. 2013 Jun 11;4(3):e00609-12. doi: 10.1128/mBio.00609-12.

31.

Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.

Busse M, Trinh I, Junk PC, Ferrero RL, Andrews PC.

Chemistry. 2013 Apr 22;19(17):5264-75. doi: 10.1002/chem.201204220. Epub 2013 Mar 27.

PMID:
23536213
32.

Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity.

Allison CC, Ferrand J, McLeod L, Hassan M, Kaparakis-Liaskos M, Grubman A, Bhathal PS, Dev A, Sievert W, Jenkins BJ, Ferrero RL.

J Immunol. 2013 Apr 1;190(7):3706-15. doi: 10.4049/jimmunol.1200591. Epub 2013 Mar 4.

33.

Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.

Andrews PC, Blair VL, Ferrero RL, Junk PC, Kumar I.

Chem Commun (Camb). 2013 Apr 11;49(28):2870-2. doi: 10.1039/c3cc40645h.

PMID:
23450139
34.

A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion system.

Gorrell RJ, Guan J, Xin Y, Tafreshi MA, Hutton ML, McGuckin MA, Ferrero RL, Kwok T.

Cell Microbiol. 2013 Apr;15(4):554-70. doi: 10.1111/cmi.12055. Epub 2012 Nov 21.

PMID:
23107019
35.

Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens.

Ferrero RL, Wilson JE, Sutton P.

Methods Mol Biol. 2012;921:157-73.

PMID:
23015503
36.

Peptidoglycan maturation enzymes affect flagellar functionality in bacteria.

Roure S, Bonis M, Chaput C, Ecobichon C, Mattox A, Barrière C, Geldmacher N, Guadagnini S, Schmitt C, Prévost MC, Labigne A, Backert S, Ferrero RL, Boneca IG.

Mol Microbiol. 2012 Nov;86(4):845-56. doi: 10.1111/mmi.12019. Epub 2012 Sep 21. Erratum in: Mol Microbiol. 2013 Apr;88(2):456-7.

37.

Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.

Andrews PC, Busse M, Deacon GB, Ferrero RL, Junk PC, MacLellan JG, Vom A.

Dalton Trans. 2012 Oct 14;41(38):11798-806. doi: 10.1039/c2dt31360j. Epub 2012 Aug 20.

PMID:
22903621
38.

The use of AlbuMAX II(®) as a blood or serum alternative for the culture of Helicobacter pylori.

Hutton ML, Kaparakis-Liaskos M, Ferrero RL.

Helicobacter. 2012 Feb;17(1):68-76. doi: 10.1111/j.1523-5378.2011.00914.x.

PMID:
22221619
39.

The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17.

Kennedy CL, Najdovska M, Jones GW, McLeod L, Hughes NR, Allison C, Ooi CH, Tan P, Ferrero RL, Jones SA, Dev A, Sievert W, Bhathal PS, Jenkins BJ.

J Pathol. 2011 Oct;225(2):255-64. doi: 10.1002/path.2933. Epub 2011 Jun 27.

PMID:
21710691
40.

In Vivo Modeling of Helicobacter-associated Gastrointestinal Diseases.

Ferrero RL, Fox JG.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 45.

41.

In Vivo Adaptation to the Host.

Ferrero RL, Jenks PJ.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 46.

42.

Vitamin B6 is required for full motility and virulence in Helicobacter pylori.

Grubman A, Phillips A, Thibonnier M, Kaparakis-Liaskos M, Johnson C, Thiberge JM, Radcliff FJ, Ecobichon C, Labigne A, de Reuse H, Mendz GL, Ferrero RL.

MBio. 2010 Aug 17;1(3). pii: e00112-10. doi: 10.1128/mBio.00112-10.

43.

Structural and solution studies of phenylbismuth(III) sulfonate complexes and their activity against Helicobacter pylori.

Andrews PC, Busse M, Deacon GB, Ferrero RL, Junk PC, Huynh KK, Kumar I, Maclellan JG.

Dalton Trans. 2010 Oct 28;39(40):9633-41. doi: 10.1039/c0dt00629g. Epub 2010 Sep 8.

PMID:
20830402
44.

Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses.

Allison CC, Ferrero RL.

Future Microbiol. 2010 Aug;5(8):1233-55. doi: 10.2217/fmb.10.84. Review.

PMID:
20722601
45.

Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells.

Hutton ML, Kaparakis-Liaskos M, Turner L, Cardona A, Kwok T, Ferrero RL.

Infect Immun. 2010 Nov;78(11):4523-31. doi: 10.1128/IAI.00439-10. Epub 2010 Aug 16.

46.

Genetic modulation of TLR8 response following bacterial phagocytosis.

Gantier MP, Irving AT, Kaparakis-Liaskos M, Xu D, Evans VA, Cameron PU, Bourne JA, Ferrero RL, John M, Behlke MA, Williams BR.

Hum Mutat. 2010 Sep;31(9):1069-79. doi: 10.1002/humu.21321.

PMID:
20652908
47.

Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria.

Foo JH, Culvenor JG, Ferrero RL, Kwok T, Lithgow T, Gabriel K.

J Mol Biol. 2010 Sep 3;401(5):792-8. doi: 10.1016/j.jmb.2010.06.065. Epub 2010 Jul 6.

PMID:
20615415
48.

Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis.

Ding SZ, Fischer W, Kaparakis-Liaskos M, Liechti G, Merrell DS, Grant PA, Ferrero RL, Crowe SE, Haas R, Hatakeyama M, Goldberg JB.

PLoS One. 2010 Apr 1;5(4):e9875. doi: 10.1371/journal.pone.0009875.

49.

Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori.

Andrews PC, Ferrero RL, Junk PC, Kumar I, Luu Q, Nguyen K, Taylor JW.

Dalton Trans. 2010 Mar 21;39(11):2861-8. doi: 10.1039/c000164c. Epub 2010 Feb 5.

PMID:
20200713
50.

The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides.

Grubman A, Kaparakis M, Viala J, Allison C, Badea L, Karrar A, Boneca IG, Le Bourhis L, Reeve S, Smith IA, Hartland EL, Philpott DJ, Ferrero RL.

Cell Microbiol. 2010 May 1;12(5):626-39. doi: 10.1111/j.1462-5822.2009.01421.x. Epub 2009 Dec 21.

PMID:
20039881

Supplemental Content

Loading ...
Support Center